STAT3 is known to regulate a number of distinct responses in different cells, including induction of an acute-phase response in hepatoma cells, stimulation of proliferation in B lymphocytes, activation of terminal differentiation and growth arrest in monocytes [4], and maintenance of the pluripotency of embryonic stem cells [13, 17–20]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.